- Developed COVID-19 antibody screening technology.
- To be used at South Texas Blood & Tissue Center (STBTC)
- Aims to find people with strong COVID-19 antibodies, who never showed any symptoms
- Paves way for True Human™ antibody therapy for COVID-19
“There is no other research or pharmaceutical organization better prepared with the technology and capabilities of XBiotech to identify and develop antibody therapies derived from natural human immunity”John Simard, XBiotech’s CEO